Market Overview:
The global cervical dysplasia diagnostic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cervical cancer, technological advancements in diagnostic devices and tests, and rising awareness about cervical dysplasia and its diagnosis. The global cervical dysplasia diagnostic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostic test and diagnostic device. The direct visualization colposcopy examination sub-segment accounted for the largest share of the global cervical dysplasia diagnostic market in 2017 owing to its high accuracy rate for diagnosing precancerous lesions or early stage cancer cells.
Product Definition:
Cervical dysplasia is a condition that affects the cells of the cervix. The cells may become abnormal in shape, size, or number. This can lead to problems such as cancer. Cervical dysplasia is diagnosed with a Pap smear.
Diagnostic Test:
The global diagnostic test market is expected to witness significant growth over the forecast period. The key drivers attributing to its rapid growth include growing prevalence of cervical cancer and other related diseases, increasing awareness about early diagnosis, and technological advancements in diagnostics tests. Moreover, rising demand for personalized medicine further propels the usage rate of these tests thereby fueling market growth during the forecast period.
Diagnostic Device:
A diagnostic device is used for the diagnosis of cervical dysplasia. It helps in identifying abnormal cells or tissue growth around or in the cervix. The diagnostic devices can be internal as well as external devices. Cervical dysplasia is also known as cervical cancer, which may develop into a serious disease if left unattended.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and others. Hospitals held the largest share in 2017 owing to availability of advanced diagnostic facilities and skilled personnel at hospitals. Furthermore, a large number of government initiatives that aim to improve access to cervical cancer screening in developing countries may boost the growth of this segment over the forecast period. The clinic segment is anticipated to witness significant growth during the study period due largely its ability to provide convenient diagnosis at an affordable cost as compared with hospital-based tests.
The others application category includes laboratories and other non-clinical facilities that offer cervical cancer testing services such as cytology analysis by microscopy or wet-lab techniques for identifying abnormal cells in cervicovaginal specimens or liquid biopsies obtained via colposcopes or endocervical curettes for further evaluation by more sophisticated methods such as conventional microscopy or molecular biology techniques such as Hybrid Capture 2 (HC2).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of this disease, increasing awareness about early diagnosis, availability of technologically advanced products and presence of key players in this region. In addition, government initiatives and public & private healthcare partnerships are also playing a vital role in promoting awareness about CervicalCheck screening program and other related services offered by the National Cervical Screening Programme Ireland (NCSPI).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising incidence rates due to lack of awareness coupled with social stigma associated with cervical cancer among women from India & China. Moreover, government initiatives for conducting population-based screening programs are also contributing towards regional growth.
Growth Factors:
- Increasing incidence of cervical cancer: The incidence of cervical cancer is increasing at an alarming rate across the globe. This is mainly due to the rising prevalence of HPV infection, which is the primary cause for development of cervical dysplasia and cancer. According to a study by World Health Organization (WHO), approximately 528,000 women died from cervical cancer in 2012, out of which 87% were from developing countries. Thus, there exists a high unmet medical need for early diagnosis and treatment of cervical dysplasia and cancers.
- Growing awareness about HPV and its association with development of cervical dysplasia: There is growing awareness among people about human papillomavirus (HPV) and its association with development of various types of cancers including cervical dysplasia. This has led to increased demand for diagnostic tests for detectionof HPV infection as well as early diagnosisand treatmentofcervicaldysplasia .
- Technological advancements in diagnostic testing: There has been significant advancement in technology used for diagnosing cervixcancerandcervicaldysplasiatoday .This has resulted in introduction oftests that are more accurateandsensitivefor detectionof precancerous lesionsin cervix . Such technological advancements are likely to fuel growthofthe Cervical Dysplasia Diagnostic market overthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Cervical Dysplasia Diagnostic Market Research Report
By Type
Diagnostic Test, Diagnostic Device
By Application
Hospitals, Clinic, Others
By Companies
Abbott Laboratories, Roche Holding AG, Hologic, Inc., Micromedic Technologies Ltd., PDS Biotechnology Corporation, Quest Diagnostics, Inc., QIAGEN N.V.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Cervical Dysplasia Diagnostic Market Report Segments:
The global Cervical Dysplasia Diagnostic market is segmented on the basis of:
Types
Diagnostic Test, Diagnostic Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Roche Holding AG
- Hologic, Inc.
- Micromedic Technologies Ltd.
- PDS Biotechnology Corporation
- Quest Diagnostics, Inc.
- QIAGEN N.V.
Highlights of The Cervical Dysplasia Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Test
- Diagnostic Device
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cervical Dysplasia Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cervical dysplasia is a condition in which the cells that line the inside of the cervix (the lower part of the uterus) are abnormal. This can cause problems during pregnancy, such as premature birth or low birth weight.
Some of the major companies in the cervical dysplasia diagnostic market are Abbott Laboratories, Roche Holding AG, Hologic, Inc., Micromedic Technologies Ltd., PDS Biotechnology Corporation, Quest Diagnostics, Inc., QIAGEN N.V..
The cervical dysplasia diagnostic market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cervical Dysplasia Diagnostic Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cervical Dysplasia Diagnostic Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cervical Dysplasia Diagnostic Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cervical Dysplasia Diagnostic Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cervical Dysplasia Diagnostic Market Size & Forecast, 2018-2028 4.5.1 Cervical Dysplasia Diagnostic Market Size and Y-o-Y Growth 4.5.2 Cervical Dysplasia Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Cervical Dysplasia Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cervical Dysplasia Diagnostic Market Size Forecast by Type
5.2.1 Diagnostic Test
5.2.2 Diagnostic Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cervical Dysplasia Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cervical Dysplasia Diagnostic Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cervical Dysplasia Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cervical Dysplasia Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cervical Dysplasia Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Cervical Dysplasia Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cervical Dysplasia Diagnostic Market Size Forecast by Type
9.6.1 Diagnostic Test
9.6.2 Diagnostic Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cervical Dysplasia Diagnostic Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cervical Dysplasia Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Cervical Dysplasia Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cervical Dysplasia Diagnostic Market Size Forecast by Type
10.6.1 Diagnostic Test
10.6.2 Diagnostic Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cervical Dysplasia Diagnostic Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cervical Dysplasia Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cervical Dysplasia Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cervical Dysplasia Diagnostic Market Size Forecast by Type
11.6.1 Diagnostic Test
11.6.2 Diagnostic Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cervical Dysplasia Diagnostic Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cervical Dysplasia Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Cervical Dysplasia Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cervical Dysplasia Diagnostic Market Size Forecast by Type
12.6.1 Diagnostic Test
12.6.2 Diagnostic Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cervical Dysplasia Diagnostic Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Market Size Forecast by Type
13.6.1 Diagnostic Test
13.6.2 Diagnostic Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cervical Dysplasia Diagnostic Market: Competitive Dashboard
14.2 Global Cervical Dysplasia Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Roche Holding AG
14.3.3 Hologic, Inc.
14.3.4 Micromedic Technologies Ltd.
14.3.5 PDS Biotechnology Corporation
14.3.6 Quest Diagnostics, Inc.
14.3.7 QIAGEN N.V.